Media

AMR Bio in the media. Explore coverage from external publications.

• DDW
  24 July 2026

  The pandemic we have trained ourselves to ignore

  Read article

• DDW
  11 June 2026

  AMR Bio confirms contribution to US national action plan

  Read article

• Manufacturing Chemist
  8 June 2026

  AMR Bio urges US policymakers on infection strategy

  Read article

• The Pharma Letter
  5 June 2026

  AMR Bio contributes to US national action plan on combating antibiotic-resistant bacteria

  Read article

• Proactive Investors
  28 May 2026

  EMV Capital advances XF-73 toward late-stage trials for surgical infection prevention

  Read article

• Life Science Daily
  25 May 2026

  Weekly News Roundup, 25 May 2026

  Read article

• Campaign Archive
  21 May 2026

  AMR Bio launches with phase III-ready antimicrobial

  Read article

• PM Live
  21 May 2026

  AMR Bio launches with phase 3-ready antimicrobial gel targeting surgical infections

  Read article

• Manufacturing Chemist
  21 May 2026

  AMR Bio launches clinical phase biotech antimicrobial XF-73

  Read article

• Proactive Investors
  21 May 2026

  EMV Capital’s AMR Bio advances infection prevention drug towards Phase III trial

  Read article

• The Pharma Letter
  20 May 2026

  AMR Bio launches with phase III-ready antimicrobial

  Read article

• FirstWord Pharma
  20 May 2026

  AMR Bio launches to advance Phase 3-ready antimicrobial XF-73

  Read article

• American Pharmaceutical Review
  20 May 2026

  AMR Bio Launches to Advance Phase 3-Ready Antimicrobial XF-73

  Read article